One Comprehensive Universal Radiotherapy for Everyone (1-CURE) Proposers' Day

SOL #: ARPA-H-SN-26-152Special Notice

Overview

Buyer

Health And Human Services
National Institutes Of Health
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Washington, DC, 20005, United States

Place of Performance

Place of performance not available

NAICS

Research and Development in the Physical (541715)

PSC

Health R&D Services; Health Care Services; Experimental Development (AN13)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Action Date
Mar 23, 2026, 4:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Advanced Research Projects Agency for Health (ARPA-H) has issued a Special Notice announcing a Proposers' Day for its new "One Comprehensive Universal Radiotherapy for Everyone" (1-CURE) program. This event aims to inform the scientific community about the program's technical areas and facilitate teaming for an anticipated Innovative Solutions Opening (ISO). The 1-CURE program seeks to develop revolutionary radiotherapy effective against all cancers. Registration for the Proposers' Day is required by March 23, 2026.

Program Overview

The 1-CURE program's objective is to develop a revolutionary radiotherapy approach effective against all cancers, utilizing FLASH-RT technology integrated with immunogenic smart radiotherapy biomaterials (SRBs). The program is structured into two key technical areas:

  • TA1: Immunogenic Nanoparticle SRBs
  • TA2: Abscopal Treatment Planning System for Low-cost FLASH-RT Applicants for the forthcoming ISO will be required to submit comprehensive proposals addressing both TA1 and TA2.

Proposers' Day Details

The Proposers' Day is an optional but encouraged event designed to provide detailed information on the 1-CURE program's goals, solution summary, proposal structure, scope, timeline, and scale. The event format includes:

  • Overview presentations
  • 3-minute lightning talks
  • 5-minute sidebar meetings Participants are encouraged to prepare a one-page slide for lightning talks (a template is provided) and a one-page "teaming profile" to identify potential partners. Registration is required and open until the day of the event, with no same-day registration available.

Opportunity Details

  • Type: Special Notice (announcing an anticipated Innovative Solutions Opening - ISO)
  • Agency: Advanced Research Projects Agency for Health (ARPA-H), under the National Institutes of Health (NIH), Health and Human Services.
  • Anticipated ISO Release: No later than March 16, 2026
  • Proposers' Day Registration Deadline: March 23, 2026 (4:00 PM ET)
  • Published Date: March 12, 2026
  • Set-Aside: None
  • Product Service Code: AN13 (Health R&D Services; Health Care Services; Experimental Development)

Action Items

Interested parties should register for the Proposers' Day, prepare their lightning talk slides and teaming profiles, and monitor for the release of the forthcoming 1-CURE Innovative Solutions Opening. Contact: The 1-CURE Team (1-CURE@ARPA-H.gov)

People

Points of Contact

The 1-CURE TeamPRIMARY

Files

Files

Download
Download

Versions

Version 1Viewing
Special Notice
Posted: Mar 12, 2026
One Comprehensive Universal Radiotherapy for Everyone (1-CURE) Proposers' Day | GovScope